Skip to content
Menu
Log In

Porter & Co

Porter & Co

Primary Menu

  • Research
  • Podcast
  • FAQ
  • About Us
    • About Our Portfolio
    • The Porter & Company Team
  • Contact
Search

Canadian pharmaceutical company Knight Therapeutics announces a huge share buyback program (from GlobeNewswire on July 12)…

Posted onJuly 23, 2023July 27, 2023AuthorPorter & Co.

This content is only available for paid members

If you are interested in learning more, or becoming a Partner, please call our Customer Care Concierge, Lance James, at 888-610-8895.
Login now

CategoriesInvestment Chronicles, Special SituationsTagsInvestment Chronicles

Post navigation

← Previous Previous post: Two notable short-sellers are targeting “AI service provider” Applied Digital Corp (from KEDM.com via Twitter on July 13)…
Next → Next post: Energy delivery firm MDU Resources (MDU) plans to spin off its construction services business (from the Securities and Exchange Commission on July 10)…

Need help with something?

I’m Lance James, your personal Porter & Co. concierge. And yes, I’m a real person. I’m here to assist with anything you need – navigating your membership, finding resources, answering questions, and more.

My number is 888-610-8895, and you can call me anytime between
9 to 5am ET, Monday to Friday.

You can also email me here.

I’m looking forward to working
with you.

Porter & Co. Logo

Get Porter in your inbox for free.

Just enter your email to receive The Big Secret on Wall Street every Friday.

Loading
© 2023 Porter & Co.
  • Legal Notices
  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Website Copyright Policy
  • Personal Information Policy
Copyright © 2023 Porter & Co. All Rights Reserved. | Porter Company Research 2023 by Porter & Co.
Scroll Up
  • Research
  • Podcast
  • FAQ
  • About Us
    • About Our Portfolio
    • The Porter & Company Team
  • Contact